Leica Biosystems and Bio-Techne Announce the US Launch of RNAscope In Situ Hybridization Automation on the BOND-PRIME Staining Platform
recent articles
Melbourne, Australia — (March 17, 2026) — Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, and Bio-Techne (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products,...
The Aiforia Prostate Cancer Biopsy AI application is designed to enhance pathologists’ diagnostic workflow by providing world-class tools for comprehensive analysis and reporting of prostate needle biopsies. Aiforia Technologies Plc, Press...
Leica Biosystems: Transformational automation accelerates time to results by up to 93.6% for cytogenetics laboratories worldwide VISTA, California – March 13, 2026 – Leica Biosystems, a Danaher company and a global leader in digital and...
Indica Labs: Learn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images! Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional...
The latest from the Proscia blog: By Ritida Nanda | March 12, 2026 Proscia has been named Global 2026 Best in KLAS for Digital Pathology in Europe and earned the top performance score in the U.S. in the 2026 KLAS Digital...
Philips: Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health...
